Dividends Calendar Earnings Calendar
CHRS

CHRS | Coherus Biosciences Inc

Coherus Biosciences Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Redwood City, California, United States

Trade prices

  • Volume:
  • Market Cap: 606.22M
  • Prev closed:
  • Open: 17.25
  • High: 17.48
  • Low: 16.47
  • 52 week low: 12.21
  • 52 week high: 22.22
  • Dividends:No Dividends

Next ER: March 6, 2023  After Market Closes



Top Stories (CHRS)

    Company Profile

    Coherus BioSciences, Inc. is a leading global biologics platform company focused on delivering high-quality biosimilar therapeutics that may expand patient access to life-changing medicines in regulated markets worldwide. In 2018, the U.S. Food and Drug Administration approved Coherus? biosimilar UDENYCA® (pegfilgrastim-cbqv). Coherus is headquartered in the heart of California?s Silicon Valley and composed of a team of industry veterans with decades of experience pioneering biologics companies.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    May 11, 2023
    March 6, 2023-0.6 / -0.845.35M / 48.41M
    November 8, 2022-0.96 / -0.7445.4M / 57.27M
    August 4, 2022-0.65 / -0.783860.15M / 62.04M
    May 5, 2022-1.24 / -0.646760.12M / 69.54M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 4, 2022 10.58 9.95
    10.81
    9.95
    1.39M 5.17%
    Aug 3, 2022 10.06 10.14
    10.75
    9.93
    1.92M 0.40%
    Aug 2, 2022 10.02 9.15
    10.05
    9.04
    1.17M 9.39%
    Aug 1, 2022 9.16 8.48
    9.38
    8.39
    1.24M 8.15%
    Jul 29, 2022 8.47 8.42
    8.50
    8.06
    781.80K 0.36%
    Jul 28, 2022 8.44 8.11
    8.51
    7.71
    963.04K 4.33%
    Jul 27, 2022 8.09 7.51
    8.11
    7.41
    1.02M 8.88%
    Jul 26, 2022 7.43 7.24
    7.58
    7.09
    924.48K 1.78%
    Jul 25, 2022 7.30 7.20
    7.31
    6.98
    859.85K 1.81%
    Jul 22, 2022 7.17 7.88
    7.89
    7.14
    1.84M -9.01%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2010
    • Employees:291

    News

    News for (CHRS)

    This company doesn't provide a dividend.


    Talk about Coherus Biosciences Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Mar 6, 2023 (Same day)

    px cara ntnx gwre cien avav chrs pgen azul ruby bbar evfm 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 50
    HOLD 50
    SELL 0

    Their Official Profiles 

    LinkedIn

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet